TY - JOUR
T1 - Radical acceleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD
AU - Hirai, Hiroyuki
AU - Tani, Tetsuya
AU - Katoku-Kikyo, Nobuko
AU - Kellner, Steven
AU - Karian, Peter
AU - Firpo, Meri
AU - Kikyo, Nobuaki
PY - 2011/9
Y1 - 2011/9
N2 - Induced pluripotent stem cells (iPSCs) can be created by reprogramming differentiated cells through introduction of defined genes, most commonly Oct4, Sox2, Klf4, and c-Myc (OSKM). However, this process is slow and extremely inefficient. Here, we demonstrate radical acceleration of iPSC creation with a fusion gene between Oct4 and the powerful transactivation domain (TAD) of MyoD (M 3O). Transduction of M 3O as well as Sox2, Klf4, and c-Myc into fibroblasts effectively remodeled patterns of DNA methylation, chromatin accessibility, histone modifications, and protein binding at pluripotency genes, raising the efficiency of making mouse and human iPSCs more than 50-fold in comparison to OSKM. These results identified that one of the most critical barriers to iPSC creation is poor chromatin accessibility and protein recruitment to pluripotency genes. The MyoD TAD has a capability of over-coming this problem. Our approach of fusing TADs to unrelated transcription factors has far-reaching implications as a powerful tool for transcriptional reprogramming beyond application to iPSC technology.
AB - Induced pluripotent stem cells (iPSCs) can be created by reprogramming differentiated cells through introduction of defined genes, most commonly Oct4, Sox2, Klf4, and c-Myc (OSKM). However, this process is slow and extremely inefficient. Here, we demonstrate radical acceleration of iPSC creation with a fusion gene between Oct4 and the powerful transactivation domain (TAD) of MyoD (M 3O). Transduction of M 3O as well as Sox2, Klf4, and c-Myc into fibroblasts effectively remodeled patterns of DNA methylation, chromatin accessibility, histone modifications, and protein binding at pluripotency genes, raising the efficiency of making mouse and human iPSCs more than 50-fold in comparison to OSKM. These results identified that one of the most critical barriers to iPSC creation is poor chromatin accessibility and protein recruitment to pluripotency genes. The MyoD TAD has a capability of over-coming this problem. Our approach of fusing TADs to unrelated transcription factors has far-reaching implications as a powerful tool for transcriptional reprogramming beyond application to iPSC technology.
KW - Embryonic stem cells
KW - Induced pluripotent stem cells
KW - MyoD
KW - Oct4
UR - http://www.scopus.com/inward/record.url?scp=80052001018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052001018&partnerID=8YFLogxK
U2 - 10.1002/stem.684
DO - 10.1002/stem.684
M3 - Article
C2 - 21732495
AN - SCOPUS:80052001018
SN - 1066-5099
VL - 29
SP - 1349
EP - 1361
JO - Stem Cells
JF - Stem Cells
IS - 9
ER -